Associated Papers
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton.
Michail C et al.
Neoplasia (new York, N.y.), 2025
Novel molecular targets for the treatment of lung cancer.
Rosell R et al.
Current Opinion in Oncology, 2020
Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer.
Kim IK et al.
Oncogene, 2019
Select a paper to view details